Stock Events

Stock Events

Santen Pharmaceutical. 

M$339.23
22
+M$0.00+0% Monday 19:41

Statistics

Day High
339.23
Day Low
339.23
52W High
339.23
52W Low
339.23
Volume
0
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.76%
Dividend
2.59

Upcoming

Dividends

0.76%Dividend Yield
Mar 26
M$2.59
Nov 25
M$2.33
Mar 25
M$2.59
Nov 24
M$2.33
Jun 24
M$1.86
10Y Growth
-6.18%
5Y Growth
0.15%
3Y Growth
0.6%
1Y Growth
17.48%

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
2.61
2.87
3.13
3.4
Expected EPS
2.605890911325
Actual EPS
N/A

Financials

9.01%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
35.05BRevenue
3.16BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, including eye care products through its Alcon division, directly competing with Santen's focus on ophthalmology.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its subsidiary Genentech, offers ophthalmic drugs, competing in the same space as Santen Pharmaceutical in treatments for eye diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is known for Eylea, an injection for certain eye conditions, directly competing with Santen's products in the ophthalmology market.
Bausch Health Companies
BHC
Mkt Cap2.36B
Bausch Health Companies, formerly Valeant Pharmaceuticals, has a significant presence in the eye health market through its Bausch + Lomb segment, making it a direct competitor to Santen.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, after acquiring Allergan, has expanded its portfolio in eye care products, including treatments for dry eye and glaucoma, competing with Santen's offerings.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its Vision Care division, offers products for eye health, including contact lenses and surgical products, competing with Santen in the broader eye care market.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has a range of treatments in the field of ophthalmology, including therapies for glaucoma and eye inflammation, making it a competitor to Santen.
Alcon
ALC
Mkt Cap34.81B
Alcon focuses on eye care products ranging from surgical devices to contact lenses, competing with Santen in the ophthalmic products market.
Merck
MRK
Mkt Cap366B
Merck & Co., although not primarily focused on eye care, has developed treatments for conditions like glaucoma, positioning it as a competitor in specific segments of the ophthalmology market.

About

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in Phase III clinical trial; DE-117 in Japan; DE-126 that is in Phase IIb clinical trial; DE-128 in Europe, as well as is in Phase II/III clinical trial in the United States; and DE-130A that is in Phase III clinical trial. In addition, the company provides DE-114A to treat allergic conjunctivitis; DE-076C for the treatment of vernal keratoconjunctivitis; and DE-109, which is in Phase III clinical trial to treat uveitis. Further, it offers DE-127 to treat myopia, which is in Phase II/III clinical trial in Japan, as well as is in Phase III in Asia; DE-089C, which has completed Phase III clinical trials for the treatment of dry eye; and STN1013400, which is in Phase I clinical trials for the treatment of myopia. Additionally, the company offers over-the-counter pharmaceutical products. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.
Show more...
CEO
ISIN
JP3336000009

Listings

STU
DE
SZD.STU
F
DE
SZD.F
MX
MX
4536.MX
MU
DE
SZD0.MU

0 Comments

Share your thoughts

FAQ

What is Santen Pharmaceutical. stock price today?▼
The current price of 4536N.MX is M$339.23 MXN — it has increased by +0% in the past 24 hours. Watch Santen Pharmaceutical. stock price performance more closely on the chart.
What is Santen Pharmaceutical. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Mexican Exchange exchange Santen Pharmaceutical. stocks are traded under the ticker 4536N.MX.
What is Santen Pharmaceutical. revenue for the last year?▼
Santen Pharmaceutical. revenue for the last year amounts to 35.05B MXN.
What is Santen Pharmaceutical. net income for the last year?▼
4536N.MX net income for the last year is 3.16B MXN.
Does Santen Pharmaceutical. pay dividends?▼
Yes, 4536N.MX dividends are paid semi-annual. The last dividend per share was 2.59 MXN. As of today, Dividend Yield (FWD)% is 0.76%.
In which sector is Santen Pharmaceutical. located?▼
Santen Pharmaceutical. operates in the Other sector.
When did Santen Pharmaceutical. complete a stock split?▼
Santen Pharmaceutical. has not had any recent stock splits.